niagenbioscience.com (NAGE) - הון עצמי של החברה

This daily price chart for Chromadex Corp (NAGE) is recorded at 0.08. Chromadex Corp dominates the creation of patented components for cell metabolism, protecting itself from cheap imitations through intellectual property rights. Revenues are based on the production of biochemical supplements, where Niagen for dietary supplements serves as the key driver. Supply chain stability is ensured by streamlined industrial transportation of chemical raw materials to the plants.

Book value reflects the actual value of the issuer's net assets minus all liabilities, determining the business's internal margin of safety. Analyzing the book value of Chromadex Corp (NAGE) allows for an assessment of the actual protection of investments against default. The metric is calculated as the difference between total assets and debts. For Chromadex Corp (NAGE), growth in this indicator confirms the effectiveness of its patent monopoly on Nicotinamide Riboside. Stable capital accumulation solidifies the company's dominance in the B2B sector of anti-aging biotechnology.